Coronary artery thromboembolism as a cause of myocardial infarction with non-obstructive coronary arteries (MINOCA).
Ceasovschih A, Mantzouranis E, Dimitriadis K, Sorodoc V, Vlachakis PK, Karanikola AE, Theofilis P, Koutsopoulos G, Drogkaris S, Andrikou I, Valatsou A, Lazaros G, Sorodoc L, Tsioufis K.
Hellenic J Cardiol. 2024 Sep-Oct;79:70-83. doi: 10.1016/j.hjc.2024.05.001. Epub 2024 May 31.
Prevention of Pulmonary and Venous Thromboembolism Post Coronary Artery Bypass Graft Surgery - Literature Review.
Jannati M, Ardecani AA.
Braz J Cardiovasc Surg. 2020 Jun 1;35(3):368-374. doi: 10.21470/1678-9741-2018-0345.
Myocardical Infarction with Non-Obstructive Coronary Arteries (MINOCA): pathogenesis, diagnosis and treatment.
Sucato V, Comparato F, Ortello A, Galassi AR.
Curr Probl Cardiol. 2024 Jul;49(7):102583. doi: 10.1016/j.cpcardiol.2024.102583. Epub 2024 Apr 26.
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr, Ellinor PT, Ezekowitz MD, Field ME, Furie KL, Heidenreich PA, Murray KT, Shea JB, Tracy CM, Yancy CW.
J Am Coll Cardiol. 2019 Jul 9;74(1):104-132. doi: 10.1016/j.jacc.2019.01.011. Epub 2019 Jan 28.
Low degree of shared genetic susceptibility to coronary artery disease and venous thromboembolism.
Zöller B.
Thromb Res. 2014 Aug;134(2):219-20. doi: 10.1016/j.thromres.2014.06.014. Epub 2014 Jun 19.
No prospective association of a polygenic risk score for coronary artery disease with venous thromboembolism incidence.
Folsom AR, de Vries PS, Cushman M.
J Thromb Haemost. 2021 Nov;19(11):2841-2844. doi: 10.1111/jth.15501. Epub 2021 Aug 31.
Coronary artery thromboembolism from left appendage mural thrombus- a rare complication from atrial fibrillation.
McCarthy S, Garland J, Wong CX, Tse R.
Forensic Sci Med Pathol. 2021 Sep;17(3):522-525. doi: 10.1007/s12024-021-00372-2. Epub 2021 Apr 23.
Antithrombotic therapy in acute myocardial infarction: prevention of venous, left ventricular and coronary artery thromboembolism.
Stein B, Fuster V.
Am J Cardiol. 1989 Jul 18;64(4):33B-40B. doi: 10.1016/s0002-9149(89)80008-6.
Anabolic steroids and cardiovascular morbidity.
Windfeld-Mathiasen J, Horwitz H, Biering-Sørensen T, Olsen FJ.
Ugeskr Laeger. 2024 Oct 14;186(42):V04240260. doi: 10.61409/V04240260.
How I treat the co-occurrence of venous and arterial thromboembolism: anticoagulation, antiplatelet therapy, or both?
May JE, Moll S.
Blood. 2024 Jun 6;143(23):2351-2362. doi: 10.1182/blood.2023021638.
